HIV Clinical Trial
— KIU!Official title:
Efficacy of Internet-based HIV Prevention
Verified date | August 2022 |
Source | Northwestern University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Young men who have sex with men (YMSM) account for almost 70% of HIV diagnoses among all young people in the U.S. and are alone in facing an increasing rate of infections. Because YMSM are less likely to receive relevant sexual health education in traditional settings (e.g. schools, community), the Internet is a unique route of reaching and helping YMSM. The purpose of this study is to compare two different versions of an online HIV prevention program for YMSM. The study is being conducted by researchers at Northwestern University in Chicago, Hunter College in New York City, and Emory University in Atlanta. A total of 900 YMSM will be enrolled into this study from the clinics of community partners in Chicago, New York, and Atlanta. Participants will be randomly assigned to one of two versions of the program. Some topics in the program include HIV facts and myths, sexually transmitted infections (STIs), and condom use. All participants, regardless of the program version they receive, will also take at-home urine and rectal tests for the STIs chlamydia and gonorrhea. After completing the program, participants will be contacted three more times over the course of a year for follow-up sessions and surveys. The research team hypothesizes that the YMSM-specific prevention program will lead to a significant reduction in the frequency of unprotected anal sex acts and new STI infections compared to the HIV knowledge program that is for a general audience. The YMSM-specific program will also lead to improvements in secondary knowledge, motivation, and skills outcomes. In order for the research team to measure the effectiveness of the YMSM-specific prevention program and determine if the study hypothesis is correct, participants will be asked questions about themselves, including questions about their sexual orientation, sexual experiences, health practices, including drug use, health knowledge, and questions about their feelings and emotions. Based on this information, the research team hopes to later change, improve, or expand the program to better address the needs of YMSM.
Status | Completed |
Enrollment | 901 |
Est. completion date | March 2017 |
Est. primary completion date | March 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 29 Years |
Eligibility | Inclusion Criteria: - Birth male who identifies as male and reports sexual contact with another male - Received an HIV negative test result from a participating clinic/recruitment site - Unprotected anal sex with another male in the last 6 months - Ability to read English at 8th grade level Exclusion Criteria: - HIV positive - Female or Transgender - No email address for contact - Currently in a monogamous relationship lasting longer than 6 months - Participated in previous versions of KIU! |
Country | Name | City | State |
---|---|---|---|
United States | Emory University | Atlanta | Georgia |
United States | Northwestern University | Chicago | Illinois |
United States | Hunter College | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Northwestern University | Emory University, Hunter College of City University of New York, National Institute on Drug Abuse (NIDA) |
United States,
Centers for Disease Control and Prevention (CDC). HIV Surveillance in Adolescents and Young Adults. 2010.
Centers for Disease Control and Prevention (CDC). Trends in HIV/AIDS diagnoses among men who have sex with men--33 states, 2001-2006. MMWR Morb Mortal Wkly Rep. 2008 Jun 27;57(25):681-6. — View Citation
Mustanski B, Lyons T, Garcia SC. Internet use and sexual health of young men who have sex with men: a mixed-methods study. Arch Sex Behav. 2011 Apr;40(2):289-300. doi: 10.1007/s10508-009-9596-1. Epub 2010 Feb 25. — View Citation
Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F, Lin LS, An Q, Mermin J, Lansky A, Hall HI; HIV Incidence Surveillance Group. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6(8):e17502. doi: 10.1371/journal.pone.0017502. Epub 2011 Aug 3. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Participant Rating of Intervention Acceptability and Tolerability | Participant rating of how much they enjoyed the intervention and participant feedback and suggestions for improvement. Range 1-4; higher scores indicate greater acceptability. | Immediately following completion of intervention (up to 3 weeks after intervention is started by participant) | |
Other | Participant Location | Log of where participants completed the intervention sessions (participants can select multiple locations). | Immediately following completion of intervention (up to 3 weeks after intervention is started by participant) | |
Other | Participant Experiences of Harm at 3 Month Follow-up | Log of any negative experiences or harm experienced by participant at three months. | 3 Months | |
Other | Participant Experiences of Harm at 6 Month Follow-up | Log of any negative experiences or harm experienced by participant at six months. | 6 Months | |
Other | Participant Experiences of Harm at 12 Month Follow-up | Log of any negative experiences or harm experienced by participant at twelve months. | 12 Months | |
Other | Occurrence of Sexually Transmitted Infections (STIs) at 3 Months | The incidence (number of new cases or diagnoses) of chlamydia and gonorrhea at 3 month follow-up. Only measured for participants who initially tested positive for chlamydia or gonorrhea at baseline. | 3 Months | |
Other | Occurrence of Sexually Transmitted Infections (STIs) at 6 Months | The incidence (number of new cases or diagnoses) of chlamydia and gonorrhea at 6 month follow-up. Only measured for participants who initially tested positive for chlamydia or gonorrhea at baseline. | 6 Months | |
Other | Level of Privacy | Log of the levels of privacy of the locations where participants completed intervention. | Immediately following completion of intervention (up to 3 weeks after intervention is started by participant) | |
Primary | Participants Self-Reporting Condomless Anal Sex at Baseline and 3 Months | Change in self-report of condomless anal sex acts at three months. | Baseline, 3 Months | |
Primary | Participants Self-Reporting Condomless Anal Sex at Baseline and 6 Months | Change in self-report of condomless anal sex acts at six months. | Baseline, 6 Months | |
Primary | Participants Self-Reporting Condomless Anal Sex at Baseline and 12 Months | Change in self-report of condomless anal sex acts at twelve months. | Baseline, 12 Months | |
Primary | Number of Participants With Occurrence of Sexually Transmitted Infections (STIs) at Baseline | The incidence (number of new cases or diagnoses) of chlamydia and gonorrhea at baseline. | Baseline | |
Primary | Number of Participants With Occurrence of Sexually Transmitted Infections (STIs) at 12 Months | The incidence (number of new cases or diagnoses) of chlamydia and gonorrhea at twelve months. | 12 months | |
Secondary | Mean Score of Condom Errors at Baseline and 3 Months | The change in frequency that a participant has not correctly used a condom (for example, starting sex without a condom or using the wrong lube with condoms) at three months. Must have reported anal sex and using a condom with a partner at both time points. Range of scores - 0-11; higher scores = more errors. | Baseline, 3 Months | |
Secondary | Percentage of Correct Responses on HIV Knowledge Assessment at Baseline and 3 Months | The change in number of HIV statements (e.g. "Only the receptive/bottom partner is at risk of being infected with HIV during anal sex", "There is a vaccine that can stop people from getting HIV", and "A natural skin (lamb skin) condom works better against HIV than does a latex condom") correctly labeled as true or false at three months. All 26 statements were recoded such that correct responses = 1 and incorrect or 'don't know' responses = 0. Composite scores were calculated to reflect the percentage of correct responses. Higher scores reflect greater knowledge of HIV transmission/risk. | Baseline, 3 Months | |
Secondary | Mean Score of Motivation and Behavioral Skills at Baseline and 3 Months | At three months, the change in:
Motivation (for example, intentions to use condoms, perceived threat of HIV or STI infection, desire to become safer) Social Norms (for example, partners, friends, or family members opinions about condom use) Behavioral Skills (for example, negotiating condom use) Motivational Self-Rating - higher score = higher motivation; range 1-4 Social Norms - higher score = higher endorsement of social norms; range 1-5 Behavioral Skills - higher score = less perceived difficulty using condoms; range 1-4 |
Baseline, 3 Months | |
Secondary | Mean Score of Health Protective Communication Skills at Baseline and 3 Months | The change in how frequently health protection (for example, condom use and regular HIV testing) is discussed with sex partners at three months. Higher score = less HPC skills; range 1-4 for each item on scale (relationship maintenance, condom use, and HIV testing). | Baseline, 3 Months | |
Secondary | Number of Participants Reporting Drug Use Before Sex at Baseline and 12 Months | The change in number of participants who report using illegal drugs or drugs not prescribed by a doctor before sex. | Baseline, 12 Month | |
Secondary | Mean Score of Condom Errors at Baseline and 6 Months | The change in frequency that a participant has not correctly used a condom (for example, starting sex without a condom or using the wrong lube with condoms) at six months. Must have reported anal sex and using a condom with a partner at both time points. Range of scores - 0-11; higher scores = more errors | Baseline, 6 Months | |
Secondary | Percentage of Correct Responses on HIV Knowledge Assessment at Baseline and 6 Months | The change in number of HIV statements (e.g. "Only the receptive/bottom partner is at risk of being infected with HIV during anal sex", "There is a vaccine that can stop people from getting HIV", and "A natural skin (lamb skin) condom works better against HIV than does a latex condom") correctly labeled as true or false at six months. All 26 statements were recoded such that correct responses = 1 and incorrect or 'don't know' responses = 0. Composite scores were calculated to reflect the percentage of correct responses. Higher scores reflect greater knowledge of HIV transmission/risk. | Baseline, 6 Months | |
Secondary | Mean Score of Motivation and Behavioral Skills at Baseline and 6 Months | At six months, the change in:
Motivation (for example, intentions to use condoms, perceived threat of HIV or STI infection, desire to become safer) Social Norms (for example, partners, friends, or family members opinions about condom use) Behavioral Skills (for example, negotiating condom use) Motivational Self-Rating - higher score = higher motivation; range 1-4 Social Norms - higher score = higher endorsement of social norms; range 1-5 Behavioral Skills - higher score = less perceived difficulty using condoms; range 1-4 |
Baseline, 6 Months | |
Secondary | Mean Score of Health Protective Communication Skills at Baseline and 6 Months | The change in how frequently health protection (for example, condom use and regular HIV testing) is discussed with sex partners at six months. Higher score = less HPC skills; range 1-4 for each item on scale (relationship maintenance, condom use, and HIV testing). | Baseline, 6 Months | |
Secondary | Mean Score of Condom Errors at Baseline and 12 Months | The change in frequency that a participant has not correctly used a condom (for example, starting sex without a condom or using the wrong lube with condoms) at twelve months. Must have reported anal sex and using a condom with a partner at both time points. Range of scores - 0-11; higher scores = more errors. | Baseline, 12 Months | |
Secondary | Percentage of Correct Responses on HIV Knowledge Assessment at Baseline and 12 Months | The change in number of HIV statements (e.g. "Only the receptive/bottom partner is at risk of being infected with HIV during anal sex", "There is a vaccine that can stop people from getting HIV", and "A natural skin (lamb skin) condom works better against HIV than does a latex condom") correctly labeled as true or false at twelve months. All 26 statements were recoded such that correct responses = 1 and incorrect or 'don't know' responses = 0. Composite scores were calculated to reflect the percentage of correct responses. Higher scores reflect greater knowledge of HIV transmission/risk. | Baseline, 12 Months | |
Secondary | Mean Score of Motivation and Behavioral Skills at Baseline and 12 Months | At twelve months, the change in:
Motivation (for example, intentions to use condoms, perceived threat of HIV or STI infection, desire to become safer) Social Norms (for example, partners, friends, or family members opinions about condom use) Behavioral Skills (for example, negotiating condom use) Motivational Self-Rating - higher score = higher motivation; range 1-4 Social Norms - higher score = higher endorsement of social norms; range 1-5 Behavioral Skills - higher score = less perceived difficulty using condoms; range 1-4 |
Baseline, 12 Months | |
Secondary | Mean Score of Health Protective Communication Skills at Baseline and 12 Months | The change in how frequently health protection (for example, condom use and regular HIV testing) is discussed with sex partners at twelve months. Higher score = less HPC skills; range 1-4 for each item on scale (relationship maintenance, condom use, and HIV testing). | Baseline, 12 Months | |
Secondary | Mean Score of Feelings of HIV Invulnerability at Baseline and 12 Months | The change in effect that HIV testing has on health beliefs (for example, "I cannot get HIV") and sexual behaviors at twelve months. Range 1-5; higher scores = more feelings of invulnerability | Baseline, 12 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |